Literature DB >> 6910355

[Experimental and clinical examinations of the effect of cryosurgery of intraocular pressure].

D Kontić, W Buschmann.   

Abstract

Diathermy and cryosurgery have different effects on living tissue. Cell membranes are ruptured by cryosurgery, but the proteins are less affected than by diathermy. A short review of experimental cyclocryosurgery and the clinical results are presented. Data from the literature as well as evaluation of patients confirm that, as yet, the results are not satisfactory. The sequelae of freezing are very different in slow-and fast-freezing procedures. Therefore, the results in rabbits treated with a cryosurgical unit used for retinal detachment surgery (Amoils, -80 degrees C) were compared with the results using a cryoprobe cooled with liquid nitrogen (-180 degrees C). A permanent reduction in intraocular pressure was not achieved using cyclocryotherapy applied with the equipment used for detachment surgery (-80 degrees C). Repeated cryosurgery of this type did not result in a permanent pressure reduction. Histopathology demonstrated that the ciliary epithelium had regenerated and prolongation of the cyclocryotherapy applications did not result in a permanent intraocular pressure reduction. Lens opacities occurred in all rabbits of this series. Application of cryotherapy with a nitrogen-cooled cryoprobe (2.5 mm2 contact area) caused severe damage, resulting in phthisis bulbi. Another nitrogen-cooled probe (contact area of about 1 mm2 diameter) resulted in a permanent reduction in intraocular pressure, but the anterior parts of the lens became opaque. Histopathology revealed total necrosis of the ciliary epithelium and the basal membrane. Three months after cyclocryotherapy of this type the ciliary processes were atrophic and covered with connective tissue and regeneration of epithelial cells was not found in areas of such cryotherapy scars. Further experiments have been commenced including a reduction of application time, in order to find the optimum application technique resulting in permanent intraocular pressure reduction and the fewest possible side effects.

Entities:  

Mesh:

Year:  1981        PMID: 6910355     DOI: 10.1007/bf00414584

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  22 in total

1.  CRYOSURGERY OF THE CILIARY BODY.

Authors:  J M MCLEAN; H A LINCOFF
Journal:  Trans Am Ophthalmol Soc       Date:  1964

2.  Histopathologic observations on human eyes following cyclocryotherapy for glaucoma.

Authors:  A P Ferry
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 Jan-Feb

3.  Cyclocryotherapy in advanced inadequately controlled glaucoma.

Authors:  A R Bellows; W M Grant
Journal:  Am J Ophthalmol       Date:  1973-04       Impact factor: 5.258

4.  Rubeosis iridis and neovascular glaucoma. Evaluation of cyclocryotherapy.

Authors:  R M Feibel; J F Bigger
Journal:  Am J Ophthalmol       Date:  1972-11       Impact factor: 5.258

5.  Cryosurgery for glaucoma.

Authors:  A DeRoetth
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1969 Nov-Dec

6.  Histopathologic changes following cryosurgery and diathermy of the rabbit ciliary body.

Authors:  C Edmonds; A De Roetth; G M Howard
Journal:  Am J Ophthalmol       Date:  1970-01       Impact factor: 5.258

7.  [Experience with cryogenic treatment of the ciliary body in glaucoma].

Authors:  C Hilsdorf
Journal:  Klin Monbl Augenheilkd       Date:  1970       Impact factor: 0.700

8.  Ciliary body temperatures in cryosurgery.

Authors:  A De Roetth
Journal:  Arch Ophthalmol       Date:  1971-02

9.  [Results of cryocoagulation of the ciliary body in various glaucomas].

Authors:  C Haye; J Haut; A Mondon
Journal:  Bull Soc Ophtalmol Fr       Date:  1967 Mar-Apr

10.  Experiences with a modified technic for cyclocryotherapy.

Authors:  H Wiesinger
Journal:  Int Surg       Date:  1967-11
View more
  1 in total

1.  Pathology of cyclodiode laser: a series of nine enucleated eyes.

Authors:  P A McKelvie; M J Walland
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.